ARTICLE | Financial News
Vernalis banks 2.75 million
December 7, 2000 8:00 AM UTC
Vernalis (LSE:VER) divested its holding in Cancer Research Ventures (London, U.K.), the licensing and technology subsidiary of Cancer Research Campaign Technology, in exchange for 2.75 million ($4 mil...